Showing 3681-3690 of 10236 results for "".
Visitation Rights
https://practicaldermatology.com/topics/practice-management/visitation-rights/20535/Tips for getting the most out of an onsite visit to a colleague's practice.Currents
https://practicaldermatology.com/topics/skin-cancer-photoprotection/currents/20659/Psoriasis and Atopic Dermatitis: Connecting the DotsCaught In The Middle
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/caught-in-the-middle/20665/Understanding how RF microneedling fits into today's cosmetic practice.11 Ways to Increase Local Reach of Your Dermatology Facebook Page
https://practicaldermatology.com/topics/practice-management/11-ways-to-increase-local-reach-of-your-dermatology-facebook-page/20673/New Products
https://practicaldermatology.com/columns/new-products/new-products/20745/Give Employee Feedback With Confidence
https://practicaldermatology.com/topics/practice-management/give-employee-feedback-with-confidence/20769/Ten tips to effectively communicate feedback to help employees grow and improve.Make Online Reviews Integral to Your Dermatology Practice Marketing
https://practicaldermatology.com/topics/practice-management/make-online-reviews-integral-to-your-dermatology-practice-marketing/20852/Get Fit
https://practicaldermatology.com/topics/practice-management/get-fit/20925/Cross-train your team for a healthy practice.Papa in at Valeant, J&J Acquires Neostrata, Celebrity Lip Envy
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-papa-in-at-valeant-j-j-acquires-neostrata-celebrity-lip-envy/18772/This edition of DermWireTV brings news that Joseph C. Papa has left Perrigo Company plc, a top five global over-the-counter consumer goods and pharmaceutical company, to take the helm as CEO at Valeant Pharmaceuticals. He will replace J. Micheal Pearson. Valeant also concluded its investigation arouWhat's New in Topical Acne Therapy
https://practicaldermatology.com/topics/practice-management/whats-new-in-topical-acne-therapy/21105/From new approvals to a growing pipeline, the outlook is bright for the continued refinement of topical acne therapy.